TheEdgeResearch
Home / Stocks / BLEVF

Beleave Inc. (BLEVF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$566
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-2.94
52-Wk Range
0.000001-0.0001
CEO
Vasilios Panagiotakopoulos
Country
CA
Currency
USD

Beleave Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Oakville, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $566. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -1423.0%. Its beta of -2.94 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
-0.50
Gross margin
34.4%
Operating margin
-989.3%
Net margin
-1423.0%
Return on equity
—
Debt / equity
1.04
Current ratio
0.41
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
16
IPO date
2016-09-28
Headquarters
Oakville, ON, CA
About Beleave Inc.

Based in Oakville, Canada, Beleave Inc. operates primarily as a medical cannabis enterprise within the country. The firm's activities include both the cultivation and distribution of cannabis products, serving both the medical and recreational sectors. Furthermore, Beleave manages a network of medical cannabis clinics across Ontario and Quebec, all branded under the Medi-Green banner. Consumers can acquire the company's offerings through its physical retail locations or via its digital storefront.

Comparable companies

Beleave Inc. is most often compared with the following Healthcare names:

ACGJARTHBUGVFGNRSGRYNMDKMMTEMMYHIORVRFWLNSF
More research on BLEVF
BLEVF technical analysis BLEVF TheEdge Score Compare against peers
Open full interactive analysis & DCF →